RONCATO, Rossana
 Distribuzione geografica
Continente #
EU - Europa 183
NA - Nord America 157
AS - Asia 22
SA - Sud America 4
AF - Africa 3
Totale 369
Nazione #
US - Stati Uniti d'America 153
IT - Italia 90
FR - Francia 42
CH - Svizzera 11
IN - India 8
DE - Germania 7
GB - Regno Unito 7
NL - Olanda 6
DK - Danimarca 5
CZ - Repubblica Ceca 3
HK - Hong Kong 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
CA - Canada 2
FI - Finlandia 2
MX - Messico 2
SE - Svezia 2
UA - Ucraina 2
UY - Uruguay 2
ZA - Sudafrica 2
AR - Argentina 1
BR - Brasile 1
IE - Irlanda 1
IR - Iran 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 369
Città #
Columbus 47
Ashburn 26
Zurich 11
Montereale Valcellina 8
Paris 7
Boardman 6
Milan 5
Council Bluffs 4
Piemonte 4
Trieste 4
Ahmedabad 3
Ardea 3
Houston 3
Romans d'Isonzo 3
Scandale 3
Arzignano 2
Bari 2
Copenhagen 2
Deiva Marina 2
Francavilla Fontana 2
Hartford 2
Jacksonville 2
Kozhikode 2
Liverpool 2
Livonia 2
London 2
Manchester 2
Miami 2
Montevideo 2
Mérida 2
Quartu Sant'Elena 2
Rome 2
Sarajevo 2
Sassari 2
Settingiano 2
Stockholm 2
Tokyo 2
Vejle 2
Azzano Decimo 1
Bangkok 1
Bengaluru 1
Brampton 1
Brockport 1
Cagliari 1
Cambridge 1
Cardiff 1
Catanzaro 1
Cattolica 1
Central 1
Chicago 1
Chieti 1
Cividale del Friuli 1
Cleveland 1
Codroipo 1
Cologne 1
Cormons 1
Cosenza 1
Dordrecht 1
Dublin 1
Fairfield 1
Fayetteville 1
Gunzenhausen 1
Helsinki 1
Kish 1
Kronberg 1
Lappeenranta 1
Los Angeles 1
Makkah 1
Marsala 1
Milpitas 1
Montpellier 1
Mountain View 1
Mumbai 1
Munro 1
Naestved 1
New York 1
Oxford 1
Padova 1
Pasadena 1
Pasay 1
Portland 1
Redmond 1
San Diego 1
Seattle 1
Spring 1
Stella Cilento 1
Szczecin 1
Toronto 1
Tunis 1
Udine 1
Velikiy Novgorod 1
Venice 1
Vicenza 1
Washington 1
Totale 239
Nome #
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy, file e27ce0c8-e681-055e-e053-6605fe0a7873 73
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy, file 875bae45-2d1a-47e2-bb87-c9338e946e13 49
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk, file 5fa2a74b-f762-4311-8bf0-1a8b772723b1 38
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure, file 5109e575-b118-4a31-9baf-0d795665211a 27
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer, file 0f67d732-f409-45d2-8b75-a37c19a6cdad 23
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome, file e27ce0c9-fa52-055e-e053-6605fe0a7873 21
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future, file 6e4998d7-29d8-47cb-90b8-4d4f6a913f14 20
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer, file 364dafa3-b48e-459b-aa4a-acc5c39cd602 19
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation, file 1bb7406d-640a-4b50-a663-43f39e790b4d 18
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions, file 3fa28d34-259c-4458-8d43-aeccb4590129 14
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm, file 4c73d2f7-b7bc-421b-9f32-a33ceb5753cc 13
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment, file d724140c-fa6f-4fe4-a97e-d4fd6c9f8d71 9
Genetic biomarkers for hepatocellular cancer risk in a caucasian population, file e54b1578-330a-4750-8725-b67d28c7ec34 9
New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach, file e2fb0455-0c97-4150-aaec-ab4f666b30a1 6
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS), file 91dfa610-a676-4271-ba39-12eeb7026d80 5
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis, file aded1304-00a6-40ab-815b-1a58573be90f 5
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer, file 1d57349d-ee87-4da2-a92a-ae5ab2c24acf 4
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy, file 3a99697c-076f-4e1a-b820-01102dc42fdf 4
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients, file 6c8c8dc1-d3b6-4785-88df-696675b4fca4 4
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy (Cell Death & Disease, (2022), 13, 4, (398), 10.1038/s41419-022-04741-9), file cc679562-7304-425f-9be5-5ade1ed76c5f 4
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients, file 3c1145fd-456d-489e-a7eb-a070fb750f04 2
Implementation of preemptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?, file 50fe1cd1-f73b-491f-8833-c93baed0ef8d 1
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine, file 6499cb9f-9934-4b3c-ac6c-bf8901b1482b 1
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity, file 919376a7-d3c8-4e15-b375-ae880e27ed92 1
Pharmacovigilance, drug interactions, pharmacogenetics and therapeutic drug monitoring of anticancer agents: a valuable support for clinical practice, file d791e42f-aa88-4cb1-80fb-fa6c8ba6c97d 1
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer, file e27ce0c9-1b23-055e-e053-6605fe0a7873 1
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines, file f74bc003-2a62-41ae-9a00-e26920165437 1
Totale 373
Categoria #
all - tutte 1.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 1 2 1 0 3 1 0 3 6
2021/202231 0 4 2 3 2 8 1 1 4 4 1 1
2022/202388 2 1 1 13 11 22 5 1 5 6 9 12
2023/2024237 13 9 16 32 5 27 10 35 3 14 73 0
Totale 373